Transitions from Bench to Clinic: Early Stage Production & Purification Development for Biologics
	Renaissance Parc 55 Hotel , San Francisco, CA August 21-23, 2000
	Great pressure from investors exists to accelerate process development while simultaneously scaling up drug supply for clinical trials. Companies need to implement early strategies to ensure continuity of development and to avoid the need to rework process development. Finally, you can attend a conference centered on aiding start-up and emerging biotechs. If you have identified a potential product and need to quickly develop validatable manufacturing processes that can be scaled-up with minimal difficulty, this program will help you succeed. This event will address the diverse yet interdependent factors that require consideration for the successful transition of therapeutic biologics from post-discovery to clinical development. For personnel in various development activities, this conference is of paramount importance. Attending Transitions from Bench to Clinic guarantees to help you avoid production pitfalls that could prevent your product from making it from early stage to commercial stage. Register early to ensure your space.
	Organized by:	IBC USA Conferences, Inc.
	Deadline for Abstracts:	-
	Registration:	Five Easy Ways to Register! Phone (508) 616-5550 Fax (508) 616-5522 E-mail reg@ibcusa.com Mail IBC USA Conferences, Inc. 1 Research Drive Suite 400A Westborough, MA 01581
	Email for Requests and Registration:	jprudhomme@ibcusa.com
	Posted by: James Prudhomme   Host: 209.6.93.46 date: May 10, 2000 19:42:49 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.